Q&A

Matthew M. Laughon, MD, MPH is a professor at the University of North Carolina (UNC) at Chapel Hill in the
department of pediatrics.

New technologies are allowing physicians to make timely decisions for cancer patients

A conversation with Dara Wright, executive vice president and president of the clinical diagnostics group at Bio-Rad

Clinical Lab Manager talks with Sandrine Miller-Montgomery, PharmD, PhD, about microbiome research and its applications in cancer research

A conversation with Dave Hickey, worldwide president of integrated diagnostic solutions at BD

Rapid and early detection of SARS-CoV-2 plays a crucial role in facilitating early intervention and treatment and preventing disease spread

Clinical Lab 2.0 is a movement that provokes the lab industry to view itself through a new value lens aligned with the forces driving the future of value-based health care

Going automated can be a lengthy process, but patients ultimately benefit

Antibiotic stewardship should be a priority for all patient-facing clinicians

How healthcare is primed for disruption

A conversation with Janice Chen, PhD, the co-founder and chief research officer of Mammoth Biosciences

A conversation with Maximilian Diehn, MD, PhD, associate professor of radiation oncology at  Stanford University

A conversation with Megan Allyse, PhD, assistant professor of biomedical ethics at Mayo Clinic

Anthony Atala, MD, discusses some of the exciting possibilities as well as existing challenges in 3-D bioprinting

Going automated can be a lengthy process, but patients ultimately benefit

George Miles, MD, PhD shares some details on his work in clinical genomics